Collaborative care model involving physicians, pharmacists improves OUD outcomes

A collaborative care model that utilizes buprenorphine-waivered physicians and community pharmacists was associated with high rates of opioid use disorder treatment retention and adherence, results of a pilot study showed.The model was also well-received from participating pharmacists, physicians and patients, according to the study authors.Less than 10% of primary care physicians in the United States have a waiver to prescribe buprenorphine, Li-Tzy Wu, DSc, MA, behavioral sciences director of the Duke Community Based Substance Use Disorder Research Program, and colleagues reported. ARead More

Share on facebook
Share on twitter
Share on linkedin